Trading Activity and Price Movement
On the trading day, Wockhardt recorded a total traded volume of 36,18,109 shares, translating into a substantial traded value of approximately ₹490.53 crores. The stock opened at ₹1,245.10 and reached an intraday high of ₹1,394.40, marking a price range of ₹169.20 within the session. The last traded price (LTP) stood at ₹1,383.10 as of 12:29 PM IST, indicating a day change of 16.14% from the previous close of ₹1,235.00.
This price performance notably outperformed the Pharmaceuticals & Biotechnology sector, which recorded a marginal decline of 0.37% on the same day, as well as the broader Sensex index, which was down by 0.16%. The stock’s upward movement followed two consecutive days of decline, signalling a potential trend reversal in the short term.
Volume and Liquidity Insights
Investor participation in Wockhardt has shown a marked increase, with delivery volume on 28 November reaching 2.49 lakh shares. This figure represents a 71.72% rise compared to the five-day average delivery volume, suggesting growing confidence among long-term investors. The weighted average price during the day indicated that a larger portion of the volume was traded closer to the lower end of the price range, reflecting some price sensitivity despite the overall upward trend.
Liquidity metrics reveal that Wockhardt is sufficiently liquid to support trade sizes of around ₹1.01 crore, based on 2% of the five-day average traded value. This level of liquidity is favourable for institutional investors and large order flows, enabling efficient execution without significant market impact.
Under the radar no more! This Large Cap from Cement is emerging from turnaround with solid fundamentals intact. Discover it while it's still relatively hidden!
- - Hidden turnaround gem
- - Solid fundamentals confirmed
- - Large Cap opportunity
Technical Indicators and Moving Averages
From a technical perspective, Wockhardt’s price is positioned above its 5-day, 20-day, and 50-day moving averages, which may indicate short to medium-term strength. However, it remains below the 100-day and 200-day moving averages, suggesting that longer-term momentum has yet to fully align with the recent gains. This mixed technical picture highlights the stock’s current phase of consolidation and potential for further directional movement depending on broader market conditions.
Market Capitalisation and Sector Context
Wockhardt is classified as a small-cap company with a market capitalisation of approximately ₹20,043 crores. Operating within the Pharmaceuticals & Biotechnology industry, the company’s performance is often influenced by sector-specific developments such as regulatory approvals, research breakthroughs, and global health trends. The sector’s modest decline on the day contrasts with Wockhardt’s strong showing, underscoring the stock’s distinct trading dynamics and investor focus.
Institutional Interest and Order Flow
The substantial traded value and volume suggest active participation from institutional investors and large traders. The rise in delivery volumes indicates that a significant portion of shares exchanged hands with the intention of holding rather than short-term speculation. This pattern often reflects confidence in the company’s fundamentals or anticipation of upcoming catalysts that could influence future valuations.
Volatility and Price Range
The wide intraday price range of ₹169.20 points to elevated volatility, which can attract traders seeking to capitalise on price swings. While the weighted average price skewed towards the lower end, the stock’s ability to touch a high of ₹1,394.40 within the session demonstrates resilience and buying interest at higher levels. Such volatility requires careful risk management for investors considering exposure to Wockhardt.
Holding Wockhardt from Pharmaceuticals & Biotechnology? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Outlook and Investor Considerations
Given the recent trading activity, Wockhardt remains a stock to watch within the Pharmaceuticals & Biotechnology sector. The combination of high-value turnover, rising delivery volumes, and a notable price range suggests that market participants are actively reassessing the company’s prospects. Investors should consider the broader sector trends, regulatory environment, and company-specific developments when analysing potential exposure.
While the stock’s short-term price action shows promise, the divergence from longer-term moving averages indicates that a sustained trend will require confirmation through consistent performance and sector support. Additionally, the liquidity profile supports sizeable trades, making Wockhardt accessible for institutional portfolios seeking exposure to pharmaceutical innovation and growth.
Overall, Wockhardt’s trading session on 1 December 2025 highlights the dynamic nature of equity markets where individual stocks can diverge from sector and index trends, driven by investor sentiment and fundamental reassessments.
Limited Time Only! Upgrade now and get 1 Year of Stock of the week worth Rs. 14,999 for FREE. Don't miss out on this exclusive offer. Claim Your Free Year →
